The size of the Global Respiratory Monitoring Devices Market was worth USD 18.22 billion in 2019 and is expected to reach USD 28.95 billion by 2024 with a CAGR of 9.7 % during the forecast period 2019 -2024.
The rising rate of geriatric population and chronic respiratory diseases due to pollution, reduced quality of air, smoking, regular chemical interaction is leading to increasing in demand for the respiratory monitoring devices market across the world. The emergence of innovative products such as cordless devices, wearables, smartphones, and integrated devices is owing to rapid advancements in technology leading to the increased adoption rate of these devices which is another major factor boosting the growth of the global respiratory monitoring devices market.
Also, key players and other medical organizations are developing active respiration monitoring devices in order to measure the capnography, respiration rate, pulse oxymetry, and pulse rate, which are fueling the growth of the respiratory monitoring devices market. Integration of technologies such as machine learning and signal analysis is also boosting the growth of respiratory monitoring devices, especially the PSG devices leading to the growth of the global respiratory monitoring devices market.
Increasing manufacturing and maintenance costs are limiting the growth rate of the respiratory monitoring devices market. High costs associated with manufacturing are restraining the growth of the global respiratory monitoring devices market to some extent.
Rising prevalence of chronic obstructive pulmonary disorders and increasing account of asthma affected population, resulting in high demand for respiratory monitoring devices is expected to create growth opportunities for the global respiratory monitoring devices market during the forecast period. Rising focus on research and development activities from the private and public organizations for developing technologically advanced monitoring devices which are integrated with advanced technologies such as wearable strain sensors in order to meet the continually rising demand and is expected to offer lucrative growth opportunities for key market players during the forecast period. The emergence of innovative products and increasing economies of developing countries such as China, India, Saudi Arabia, and others are also likely to create lucrative growth opportunities for the global respiratory monitoring devices market during the forecast period.
Key happenings in this market in the recent past:
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2018 – 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 – 2024 |
|
Segments Analysed |
By Diagnostic Devices, Therapeutic Devices, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Analysed |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
|
Companies Analysed |
Covidien GE Healthcare, Philips Healthcare, Siemens Healthcare, Resmed, Merck & Co. Inc, Calondo Pharmaceuticals Inc., Quark Pharmaceuticals Inc., Access Pharmaceuticals Inc., Sirnaomics Inc., and Traversa Therapeutics Inc. |
This research report on the Global Respiratory Monitoring Devices Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.
Respiratory Monitoring Devices Market Analysis - By Diagnostic Devices:
Respiratory Monitoring Devices Market Analysis - By Monitoring Devices:
On the basis of monitoring devices, the Pulse Oximeters segment is expected to dominate the market because of their accurate and fast results and predicted to be the top segment for the coming years too because of its better diagnostic results compared to others.
Regional Analysis:
North America Dominates the Global Respiratory Monitoring Devices Market with a share of 37% and is expected to stay at the top for a few more years. Asia-Pacific is increasing at the highest CAGR because of an increase in technological advancements and a rise in disposable incomes.
List of key market players leading the Global Respiratory Monitoring Devices Market profiled in the report are:
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Diagnostic Devices
5.1.2.1 Spirometers
5.1.2.2 Peak Flow Meters
5.1.3 Monitoring Devices
5.1.3.1 Sleep Test Devices
5.1.3.2 Gas Analyzers
5.1.3.3 Pulse Oximeters
5.1.3.4 Capnographs
5.1.4 Y-o-Y Growth Analysis, By Type
5.1.5 Market Attractiveness Analysis, By Type
5.1.6 Market Share Analysis, By Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Covidien
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 GE Healthcare
8.3 Philips Healthcare
8.4 Siemens Healthcare
8.5 Resmed
8.6 Merck & Co. Inc.
8.7 Calondo Pharmaceuticals Inc.
8.8 Quark Pharmaceuticals Inc.
8.9 Access Pharmaceuticals Inc.
8.10 Sirnaomics Inc.
8.11 Traversa Therapeutics Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
